Sanofi, joining other drug makers, slashes US insulin price

French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.

Leave A Comment

Your email address will not be published. Required fields are marked *